FSLR
57
-4
SO
55
13
K
65
2
PPL
49
2
FTI
81
3
PEP
32
2
TROW
37
5
EW
43
6
D
53
5
RSG
53
3
CNX
49
7
CLX
68
2
GOOGL
54
-4
AZO
56
4
CHD
26
2
MTCH
42
-4
ICE
45
3
AIG
32
-3
ADM
22
-2
COF
47
-2
FSLR
57
-4
SO
55
13
K
65
2
PPL
49
2
FTI
81
3
PEP
32
2
TROW
37
5
EW
43
6
D
53
5
RSG
53
3
CNX
49
7
CLX
68
2
GOOGL
54
-4
AZO
56
4
CHD
26
2
MTCH
42
-4
ICE
45
3
AIG
32
-3
ADM
22
-2
COF
47
-2
Financhill
Back

Kandi Technologies Group Vs. Crinetics Pharmaceuticals Industry Stock Comparison

Sell
23

KNDI
Kandi Technologies Group

Last Price:
$1.03
Seasonality Move:
-0.79%
Sell
8

CRNX
Crinetics Pharmaceuticals

Last Price:
$40.59
Seasonality Move:
-9.08%
Sell
23
Kandi Technologies Group (KNDI) is a Sell

Is Kandi Technologies Group a Buy, Sell or Hold?

  • The current Kandi Technologies Group [KNDI] share price is $1.06. The Score for KNDI is 23, which is 54% below its historic median score of 50, and infers higher risk than normal.
  • KNDI is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
8
Crinetics Pharmaceuticals (CRNX) is a Sell

Is Crinetics Pharmaceuticals a Buy, Sell or Hold?

  • The current Crinetics Pharmaceuticals [CRNX] share price is $48.50. The Score for CRNX is 8, which is 84% below its historic median score of 50, and infers higher risk than normal.
  • CRNX is currently trading in the 0-10% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.

KNDI Stock Price Chart

What is Kandi Technologies Group's stock price today?

  • The Kandi Technologies Group share price today is $1.06
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and KNDI is experiencing selling pressure, which indicates risk of future bearish movement.

CRNX Stock Price Chart

What is Crinetics Pharmaceuticals's stock price today?

  • The Crinetics Pharmaceuticals share price today is $48.50
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CRNX is experiencing slight selling pressure.

KNDI Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.02 Sell
Relative Strength Index (14 RSI): 49.15 Sell
Chaikin Money Flow: -104657 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (0.94 - 1.1) Buy
Bollinger Bands (100): (1.12 - 1.74) Sell

CRNX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -1.69 Sell
Relative Strength Index (14 RSI): 34.32 Sell
Chaikin Money Flow: -235099 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (51.1 - 56.94) Sell
Bollinger Bands (100): (51.5 - 57.46) Sell

KNDI Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 1.07 Sell
20-day SMA: 1.01 Buy
50-day SMA: 1.15 Sell
200-day SMA: 1.76 Sell
8-day EMA: 1.06 Sell
20-day EMA: 1.05 Buy
50-day EMA: 1.17 Sell
200-day EMA: 1.72 Sell

CRNX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 50.85 Sell
20-day SMA: 53.18 Sell
50-day SMA: 55.63 Sell
200-day SMA: 51.03 Sell
8-day EMA: 50.82 Sell
20-day EMA: 52.67 Sell
50-day EMA: 54.22 Sell
200-day EMA: 49.96 Sell

Kandi Technologies Group Earnings Growth & KNDI Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Crinetics Pharmaceuticals Earnings Growth & CRNX Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.16 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.18 per share, and a decrease next year of $0.47 per share.

Kandi Technologies Group Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Crinetics Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):